These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11891066)

  • 1. Drug delivery to the nail following topical application.
    Murdan S
    Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transungual drug delivery: current status.
    Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
    Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the nail permeability of topically applied drugs.
    Murdan S
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iontophoretic drug delivery across the nail.
    Delgado-Charro MB
    Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1st meeting on topical drug delivery to the nail.
    Murdan S
    Expert Opin Drug Deliv; 2007 Jul; 4(4):453-5. PubMed ID: 17683257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
    Kreutz T; de Matos SP; Koester LS
    Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.
    Chen K; Puri V; Michniak-Kohn B
    AAPS J; 2021 Jan; 23(1):25. PubMed ID: 33439400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A platform for predicting and enhancing model drug delivery across the human nail plate.
    Vaka SR; Murthy SN; O'Haver JH; Repka MA
    Drug Dev Ind Pharm; 2011 Jan; 37(1):72-9. PubMed ID: 20545509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transungual delivery: deliberations and creeds.
    Thatai P; Sapra B
    Int J Cosmet Sci; 2014 Oct; 36(5):398-411. PubMed ID: 24888698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
    Brown M; Turner R; Wevrett SR
    Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic approach to the formulation of anti-onychomycotic nail patches.
    Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
    Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nail disorders in older people, and aspects of their pharmaceutical treatment.
    Murdan S
    Int J Pharm; 2016 Oct; 512(2):405-411. PubMed ID: 27180233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of nail psoriasis by topical drug delivery: a pharmaceutical perspective.
    Thatai P; Khan AB
    Int J Dermatol; 2020 Aug; 59(8):915-925. PubMed ID: 32239692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and management strategies of onychomycosis.
    Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
    J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.